Noncarious cervical lesions: Response from a 25-year clinical follow-up study.

STATEMENT OF PROBLEM: The etiology and diagnosis of noncarious cervical lesions (NCCLs) remain poorly understood. PURPOSE: The purpose of this clinical study was to examine NCCL progression in an existing group of participants, establish the incidence of new NCCLs in a 25-year follow-up study, and relate them to possible risk factors, including occlusal factors. MATERIAL AND METHODS: Thirty-three participants who had completed a questionnaire about their habits, diet, and personal information were evaluated in this observational retrospective study. Impressions were made, and casts from 3 time periods (Phase I in 1996, Phase II in 1999, and Phase III in 2021) were scanned to obtain digital casts. The casts were then evaluated in a 3-dimensional analysis software program (Geomagic Control; 3D Systems) to establish digital comparisons between NCCLs and occlusal wear. Furthermore, data from an occlusal analysis device (T-Scan; Tekscan) collected in Phase I was used to analyze occlusal interferences relating to the progression of NCCLs. The statistical analysis applied nonparametric tests, followed by the assessment of the association between NCCLs and risk factors, including occlusal wear, through binary logistic regression (α=.05). RESULTS: At the end of Phase III, 7 new individuals with NCCLs were detected compared with Phase II. The median percentage progression of NCCLs per participant was 0.0% in Phase I, 7.1% in Phase II, and 35.7% in Phase III (P<.005). Occlusal wear in Phase I was associated with 5.02 times the occurrence of NCCLs in Phase III; occlusal wear in Phase II was associated with 4.73 times the occurrence of NCCLs in Phase III; and occlusal wear in Phase III was associated with 1.94 times the occurrence of NCCLs in Phase III (P<.001). Occlusal interference in border movements of the mandible was associated with a 3.55 times greater chance of presenting NCCLs in Phase III (P<.001). Additionally, statistically significant risk factors for the presence of NCCLs in Phase III were an acidic diet (P=.043) and alcohol consumption (P=.021). CONCLUSIONS: The 25-year data showed an association between NCCLs and specific risk factors, including occlusal wear and occlusal interferences.

In vitro evaluation of physicochemical properties of soft lining resins after incorporation of chlorhexidine.

STATEMENT OF PROBLEM: Incorporating chlorhexidine into soft lining materials has been suggested to reduce biofilm development on the material surface and treat denture stomatitis. However, evaluation of the physicochemical properties of this material is necessary. PURPOSE: The purpose of this in vitro study was to evaluate the physicochemical properties of resin-based denture soft lining materials modified with chlorhexidine diacetate (CDA). MATERIAL AND METHODS: Two soft lining resins were tested, one based on polymethyl methacrylate (PMMA) and the other on polyethyl methacrylate (PEMA), into which 0.5%, 1.0%, or 2.0% of CDA was incorporated; the control group had no CDA. The specimens were stored for 2 hours, 48 hours, 7, 14, 21, and 28 days and then analyzed for polymer crystallinity, Shore A hardness, degree of monomer conversion, residual monomer leaching, and CDA release. Data were analyzed by using a 3-way ANOVA and the Tukey HSD test (α=.05). RESULTS: The polymer crystallinity of PEMA and PMMA did not change after CDA incorporation. Shore A hardness increased over time, but not for any CDA concentrations tested after 28 days (P>.05). Considering the degree of conversion, PMMA-based resin showed no statistically significant difference (P>.05). However, PEMA-based resin showed a significant decrease (P<.05), which was reflected in a significant increase in residual monomer leaching from PEMA-based resin with the incorporation of 0.5% and 1.0% CDA (P<.05), mainly in the first 48 hours. PMMA-based resin showed no change in monomer leaching (P>.05). For both resins, the CDA release kinetics were related to monomer leaching; for PEMA-based resin, the values were significantly higher in the first 48 hours (P<.05), and for PMMA-based resin, the values were more sustained up to the last day of analysis. CONCLUSIONS: The incorporation of CDA did not affect the physicochemical properties of soft resins. The properties of PMMA were better than those of PEMA.

Evaluation of polymethyl methacrylate containing chlorhexidine: A randomized, controlled, split-mouth in situ study.

PURPOSE: To evaluate the antimicrobial action and elemental composition of chlorhexidine (CHX) diacetate in acrylic resins based on PMMA (polymethyl methacrylate) in situ. In addition, ex vivo evaluation of the CHX release mechanism was performed over a 14-day period. METHODS: Three discs of PMMA incorporating CHX and three control discs were mounted on individual oral splints and exposed to the oral cavity of 32 participants for 24 hours. The antimicrobial activity was evaluated by the plate count method. In the second test, elemental analysis of the specimens (n = 10) was performed by X-ray fluorescence before and after use of the device. Chlorhexidine release over a 14-day period was evaluated ex vivo in saliva samples collected from five individuals through proton nuclear magnetic resonance spectroscopy ( ¹H NMR) (500 MHz). RESULTS: Bacterial adhesion, evaluated by the plate count method, did not differ between the experimental material and control. (P> 0.05) The presence of the CHX molecule was detected by X-ray fluorescence before and after insertion of discs containing CHX into the oral cavity of participants. With regard to release, CHX was detected in saliva samples for 14 days and highest during the first 24 hours. When partial least squares discriminant analysis (PLS-DA) was applied in ¹H NMR, we observed a greater difference between the test and control groups. CLINICAL SIGNIFICANCE: The sustained release of CHX from PMMA suggests that such materials may be convenient for reducing the development of biofilm on the surface of the material for use in dentures and temporary restorative materials.

Evaluation of the physical and antifungal effects of chlorhexidine diacetate incorporated into polymethyl methacrylate.

OBJECTIVE: This study aimed to evaluate the physical properties and antifungal activities of polymethyl methacrylate (PMMA) acrylic resins after the incorporation of chlorhexidine diacetate salt (CDA). METHODOLOGY: First, acrylic resin specimens were fabricated with Vipi Cor® and DuraLay® resins with and without the incorporation of 0.5%, 1.0% or 2.0% CDA. The residual monomer and CDA release were measured at intervals ranging from 2 hours to 28 days using ultraviolet spectrometry combined with high-performance liquid chromatography. The antifungal activity against C. albicans was evaluated with the agar diffusion method. Fourier transform infrared spectroscopy was used to analyze the degree of resin conversion. Finally, the water sorption values of the resins were also measured. RESULTS: The incorporated CDA concentration significantly changed the rate of CDA release (p<0.0001); however, the brand of the material appeared to have no significant influence on drug release. Subsequently, the inhibition zones were compared between the tested groups and within the same brand, and only the comparisons between the CDA 2% and CDA 1% groups and between the CDA 1% and CDA 0.5% groups failed to yield significant differences. Regarding the degrees of conversion, the differences were not significant and were lower only in the CDA 2% groups. Water sorption was significantly increased at the 1.0% and 2.0% concentrations. CONCLUSIONS: We concluded that the incorporation of CDA into PMMA-based resins enabled the inhibition of C. albicans growth rate, did not alter the degrees of conversion of the tested resins and did not change the release of residual monomers.

Evaluation of the physical and antifungal effects of chlorhexidine diacetate incorporated into polymethyl methacrylate

Abstract This study aimed to evaluate the physical properties and antifungal activities of polymethyl methacrylate (PMMA) acrylic resins after the incorporation of chlorhexidine diacetate salt (CDA). Methodology: First, acrylic resin specimens were fabricated with Vipi Cor® and DuraLay® resins with and without the incorporation of 0.5%, 1.0% or 2.0% CDA. The residual monomer and CDA release were measured at intervals ranging from 2 hours to 28 days using ultraviolet spectrometry combined with high-performance liquid chromatography. The antifungal activity against C. albicans was evaluated with the agar diffusion method. Fourier transform infrared spectroscopy was used to analyze the degree of resin conversion. Finally, the water sorption values of the resins were also measured. Results: The incorporated CDA concentration significantly changed the rate of CDA release (p<0.0001); however, the brand of the material appeared to have no significant influence on drug release. Subsequently, the inhibition zones were compared between the tested groups and within the same brand, and only the comparisons between the CDA 2% and CDA 1% groups and between the CDA 1% and CDA 0.5% groups failed to yield significant differences. Regarding the degrees of conversion, the differences were not significant and were lower only in the CDA 2% groups. Water sorption was significantly increased at the 1.0% and 2.0% concentrations. Conclusions: We concluded that the incorporation of CDA into PMMA-based resins enabled the inhibition of C. albicans growth rate, did not alter the degrees of conversion of the tested resins and did not change the release of residual monomers.

Avaliação da atividade antimicrobiana, análise elementar e da lixiviação da resina acrílica autopolimerizável modificada pela incorporação de clorexidina / Evaluation of the antimicrobial, elemental analysis and release of the self-cured acrylic resin modified by the incorporation of chlorhexidine

O objetivo principal do presente estudo, considerando a importância do controle do biofilme, foi avaliar in situ a ação antimicrobiana e análise elementar da incorporação de diacetato de clorexidina(CHX) em resinas acrílicas a base de PMMA. Além disso, avaliar ex vivo o mecanismo de lixiviação da clorexidina por até 14 dias. Primeiramente, foram recrutados 32 indivíduos para utilização de dispositivos acrílicos intraorais palatinos por 24 horas contendo 6 corpos de prova(CPs), sendo subdivididos em 2 grupos: com clorexidina (1%) e sem CHX. A avaliação da atividade antimicrobiana foi realizada por meio de contagem de colônias de microorganismos totais e Estreptococos do grupo mutans. Então, os grupos foram avaliados estatisticamente pelo teste de wilcoxon. A análise estatística aplicada foi o teste de Wilcoxon. No segundo teste, foi feita a análise elementar dos CPs(n=10) por meio das médias das intensidade dos elementos, antes e após o uso do dispositivo, por meio da fluorescência de raio X. Ao final, foi avaliado ex vivo a liberação de clorexidina cumulativa, em meio fechado contendo saliva dos indivíduos(n=5) por até 14 dias, através da ressonância magnética nuclear (RMN). As análises estatísticas da RMN, foram avaliadas pelo programa AMIX e metaboloanalyst. Os resultados mostraram, que para atividade antimicrobiana não houve diferença estatística (p>0,05) entre os grupos. Foi detectado a presença da molécula de clorexidina, antes e após a inserção dos CPs com CHX na cavidade bucal. Já para liberação de clorexidina, foi detectada a droga ao longo de 14 dias em meio fechado para a grupo teste, com liberação maior nas primeiras 24 horas. Conclui-se que, foi comprovada a presença do fármaco na resina acrílica após 24 horas em meio bucal, e seu mecanismo de lixiviação no meio fechado por até 14 dias. Porém, não foram encontrados resultados que confirmem a presença de um potencial antimicrobiano do fármaco, nas concentrações utilizadas nos corpos de prova in situ em 24 horas.

The main objective of the present study, considering the importance of biofilm control, was to evaluate in situ the antimicrobial action and elemental composition of the incorporation of chlorhexidine diacetate (CHX) in acrylic resins based on PMMA. In addition, ex vivo evaluation of the chlorhexidine release mechanism to 14 days. Firstly, 32 individuals were recruited for 24-hour palatal intraoral acrylic devices containing 6 test specimens (SPs), divided into 2 groups: with chlorhexidine (1%) and without CHX. The evaluation of the antimicrobial activity was performed by colonies count of total microorganisms and streptococci mutans group. Then, the groups were statistically evaluated by the wilcoxon test. The statistical analysis applied was the Wilcoxon test. In the second test, elemental analysis of the SPs (n = 10) was done by means of the means intensity of the elements, before and after the use of the device, by X-ray fluorescence. At the end, the release was evaluated ex vivo of cumulative chlorhexidine in a becker containing saliva of the individuals (n = 5) for 14 days, through nuclear magnetic resonance (NMR). The NMR analyzes were evaluated by AMIX and metaboloanalyst. The results showed that for antimicrobial activity there was no statistical difference (p> 0.05) between the groups. The presence of the chlorhexidine molecule was detected before and after the insertion of SPs with CHX in the oral cavity. As for chlorhexidine release, the drug was detected over 14 days in a closed medium for the test group, with a greater release in the first 24 hours. It was concluded that the presence of the drug in the acrylic resin after 24 hours in oral cavity was verified, and its release mechanism in the closed local for 14 days. However, no results were found to confirm the presence of an antimicrobial potential of the drug at the concentrations used in the in situ test specimens in 24 hours